ACTIVE SUBSTANCE / INN

SOLRIAMFETOL

Brand name(s): Sunosi, SOLRIAMFETOL
FDA LISTED
EMA LISTED
AUTHORISED
NONE (TENTATIVE APPROVAL)
ANDA218654
Narcolepsy;Sleep Apnea, Obstructive
ACTIVE SUBSTANCE
Solriamfetol
REGULATORS
FDA · EMA
SPONSORS / MAH
Atnahs Pharma Netherlands B.V., HETERO LABS LIMITED
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SOLRIAMFETOLANDA218654HETERO LABS LIMITEDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SunosiAtnahs Pharma Netherlands B.V.Authorised16/01/2020Narcolepsy;Sleep Apnea, Obstructive

FULL INTELLIGENCE ON SOLRIAMFETOL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →